India The New China For Pharma?

What’s up with the global pharmaceutical industry? Before, China was said to be the go-to destination for pharmaceutical research and manufacturing services. Chinese drug makers were said to offer cost-effectiveness and quicker production. But, the tides may be turning. It seems like major players may be actively exploring alternatives to China for drug production. Why? There may be concerns over geopolitical tensions, disruptions caused by the COVID-19 pandemic and supply chain vulnerabilities. And who may be coming out on top because of issues with China? Could be India. According to Reuters, Indian manufacturers might emerge as the front-runners in the race for pharmaceutical supremacy. Because Indian biotech firms may be seeing a surge from global industry execs. API (Active Pharmaceutical Ingredients) are components in medications.

Rizing Premium Save BIG.The Rizing Gold Plan: ₹1299/-

X